Follow-up after oral cancer treatment-Transition to a personalized approach.
Oral cancer
routine follow-up
second primary tumour
surveillance
survivorship care
Journal
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
ISSN: 1600-0714
Titre abrégé: J Oral Pathol Med
Pays: Denmark
ID NLM: 8911934
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
26
11
2020
accepted:
28
11
2020
pubmed:
4
12
2020
medline:
5
5
2021
entrez:
3
12
2020
Statut:
ppublish
Résumé
Guidelines for follow-up after oral cancer treatment are not site-specific and encompass the entire head and neck area rather than the oral cavity alone. This one-size-fits-all protocol disregards the differences in aetiology, treatment and differential distribution of new disease between the subsites. With the effectiveness of follow-up in early detection of new disease being put into question, the focus of follow-up programmes might shift to other aspects of survivorship care. Personalization of follow-up is important, considering patient-specific features and needs. Furthermore, the COVID-19 pandemic urges us to rethink our follow-up practice. This paper discusses ways in which routine follow-up in patients treated for oral cancer can be optimized. Patients with a high risk of new disease might benefit from an intensified follow-up regimen, whilst patients with a low risk of new disease, a low chance of cure or limited life expectancy could benefit from a de-intensified follow-up regimen. The latter could include a shorter follow-up period and focus on goals other than early detection of new disease. Education of patients to report new symptoms early is of vital importance as the majority of new disease presents symptomatically. Other health care professionals such as specialist nurses and dentists need to play an important leading role in survivorship care. Remote consultations may be useful to perform more efficient and patient-centred follow-up care. Routine follow-up needs to be seen as an integrated part of an individualized survivorship plan that is provided by the entire multidisciplinary team.
Sections du résumé
BACKGROUND
BACKGROUND
Guidelines for follow-up after oral cancer treatment are not site-specific and encompass the entire head and neck area rather than the oral cavity alone. This one-size-fits-all protocol disregards the differences in aetiology, treatment and differential distribution of new disease between the subsites. With the effectiveness of follow-up in early detection of new disease being put into question, the focus of follow-up programmes might shift to other aspects of survivorship care. Personalization of follow-up is important, considering patient-specific features and needs. Furthermore, the COVID-19 pandemic urges us to rethink our follow-up practice.
FINDINGS
RESULTS
This paper discusses ways in which routine follow-up in patients treated for oral cancer can be optimized. Patients with a high risk of new disease might benefit from an intensified follow-up regimen, whilst patients with a low risk of new disease, a low chance of cure or limited life expectancy could benefit from a de-intensified follow-up regimen. The latter could include a shorter follow-up period and focus on goals other than early detection of new disease. Education of patients to report new symptoms early is of vital importance as the majority of new disease presents symptomatically. Other health care professionals such as specialist nurses and dentists need to play an important leading role in survivorship care. Remote consultations may be useful to perform more efficient and patient-centred follow-up care.
CONCLUSION
CONCLUSIONS
Routine follow-up needs to be seen as an integrated part of an individualized survivorship plan that is provided by the entire multidisciplinary team.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
429-434Informations de copyright
© 2020 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Références
Crawford B, Greenberg DD. Introduction to Cancer Surveillance Strategies. In: Johnson FE, ed. Patient Surveillance After Cancer Treatment. New York, Heidelberg, Dordrecht, London: Humana/Springer; 2013:9-14.
Health Council of the Netherlands. Follow-up in oncology. Identify objectives, substantiate actions. The Hague: Health Council of the Netherlands; 2007.
Brands MT, Brennan PA, Verbeek ALM, Merkx MAW, Geurts SME. Follow-up after curative treatment for oral squamous cell carcinoma. A critical appraisal of the guidelines and a review of the literature. Eur J Surg Oncol. 2018;44(5):559-565.
Morris LG, Sikora AG, Patel SG, Hayes RB, Ganly I. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. J Clin Oncol. 2011;29(6):739-746.
De Zoysa N, Lee A, Joshi A, et al. Developing a follow-up surveillance protocol in head and neck oncological surgery: enhanced 'traffic light' surveillance - a prospective feasibility study. Clin Otolaryngol. 2017;42(2):446-450.
Ali H, Sinnott SJ, Corcoran P, Deady S, Sharp L, Kabir Z. Oral cancer incidence and survival rates in the Republic of Ireland, 1994-2009. BMC Cancer. 2016;16(1):950.
van Dijk BA, Brands MT, Geurts SM, Merkx MA, Roodenburg JL. Trends in oral cavity cancer incidence, mortality, survival and treatment in the Netherlands. Int J Cancer. 2016;139(3):574-583.
Patel MA, Blackford AL, Rettig EM, Richmon JD, Eisele DW, Fakhry C. Rising population of survivors of oral squamous cell cancer in the United States. Cancer. 2016;122(9):1380-1387.
Cheraghlou S, Schettino A, Zogg CK, Judson BL. Changing prognosis of oral cancer: An analysis of survival and treatment between 1973 and 2014. Laryngoscope. 2018;128(12):2762-2769.
Kanatas A, Bala N, Lowe D, Rogers SN. Outpatient follow-up appointments for patients having curative treatment for cancer of the head and neck: are the current arrangements in need of change? Br J Oral Maxillofac Surg. 2014;52(8):681-687.
Kothari P, Trinidade A, Hewitt RJD, Singh A, O'Flynn P. The follow-up of patients with head and neck cancer: an analysis of 1,039 patients. Eur Arch Otorhinolaryngol. 2011;268(8):1191-1200.
Brands MT, Smeekens EAJ, Takes RP, et al. Time patterns of recurrence and second primary tumors in a large cohort of patients treated for oral cavity cancer. Cancer Med. 2019;8(12):5810-5819.
Brands MT, Merkx MAW, Geurts SME, Brennan PA. Should we be rethinking follow-up for oral cancer patients? J Oral Pathol Med. 2017;46(9):665-666.
Kerawala CJ, Newlands C, Coombes D. Follow-up after treatment of squamous cell carcinoma of the oral cavity: current maxillofacial practice in the United Kingdom. Br J Oral Maxillofac Surg. 2007;45(5):361-363.
National Cancer institute. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/survivorship. Accessed September 26th, 2019
National Cancer Policy Board. Committee on Cancer Survivorship: Improving Care and Quality of Life. From cancer patient to cancer survivor - lost in transition. Washington D.C.: 2006.
Huibertse LJ, van Eenbergen M, de Rooij BH, et al. Cancer survivors' preference for follow-up care providers: a cross-sectional study from the population-based PROFILES-registry. Acta Oncol. 2017;56(2):278-287.
Pagedar NA, Kendell N, Christensen AJ, Thomsen TA, Gist M, Seaman AT. Head and neck cancer survivorship from the patient perspective. Head Neck. 2020;42(9):2431-2439.
Patel SG, Shah JP. TNM staging of cancers of the head and neck: striving for uniformity among diversity. CA Cancer J Clin. 2005;55(4):242-258; quiz 261-242, 264.
Datema FR, Ferrier MB, Vergouwe Y, et al. Update and external validation of a head and neck cancer prognostic model. Head Neck. 2013;35(9):1232-1237.
Shen W, Sakamoto N, Yang L. Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis. Ann Surg Oncol. 2015;22(1):264-271.
Mirza AH, Aylin P, Middleton S, King EV, Nouraei RAR, Repanos C. Impact of social deprivation on the outcome of major head and neck cancer surgery in England: A national analysis. Head Neck. 2019;41(3):692-700.
Johnson S, McDonald JT, Corsten MJ. Socioeconomic factors in head and neck cancer. J Otolaryngol Head Neck Surg. 2008;37(4):597-601.
Purkayastha M, McMahon AD, Gibson J, Conway DI. Trends of oral cavity, oropharyngeal and laryngeal cancer incidence in Scotland (1975-2012) - A socioeconomic perspective. Oral Oncol. 2016;61:70-75.
Guizard AV, Dejardin O, Launay L, et al. What are the real waiting times for therapeutic management of head and neck cancer: a study in the general population in the north-west of France. Eur Arch Otorhinolaryngol. 2016;273(11):3951-3958.
Adrien J, Bertolus C, Gambotti L, Mallet A, Baujat B. Why are head and neck squamous cell carcinoma diagnosed so late? Influence of health care disparities and socio-economic factors. Oral Oncol. 2014;50(2):90-97.
Massa ST, Pipkorn P, Jackson RS, Zevallos JP, Mazul AL. Access to a regular medical provider among head and neck cancer survivors. Head Neck. 2020;42(9):2267-2276.
Stubbs VC, Rajasekaran K, Chen J, Cannady SB, Brant JA, Newman JG. Impact of payer status on survival in parotid malignancy. Am J Otolaryngol. 2019;40(4):555-559.
Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol. 2008;9(3):222-231.
Denis F, Basch E, Septans AL, et al. Two-Year Survival Comparing Web-Based Symptom Monitoring vs Routine Surveillance Following Treatment for Lung Cancer. JAMA. 2019;321(3):306-307.
Melissant HC, Verdonck-de Leeuw IM, Lissenberg-Witte BI, Konings IR, Cuijpers P, Van Uden-Kraan CF. 'Oncokompas', a web-based self-management application to support patient activation and optimal supportive care: a feasibility study among breast cancer survivors. Acta Oncol. 2018;57(7):924-934.
van der Hout A, van Uden-Kraan CF, Holtmaat K, et al. Role of eHealth application Oncokompas in supporting self-management of symptoms and health-related quality of life in cancer survivors: a randomised, controlled trial. Lancet Oncol. 2020;21(1):80-94.
Manne S, Hudson S, Frederick S, et al. e-Health self-management intervention for oral and oropharyngeal cancer survivors: design and single-arm pilot study of empowered survivor. Head Neck. 2020;42(11):3375-3388. https://doi.org/10.1002/hed.26403
Zhang Z, Xiao W, Jia J, et al. The effect of combined application of pentoxifylline and vitamin E for the treatment of osteoradionecrosis of the jaws: a meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2020;129(3):207-214.
Lambertoni A, Gravante G, Battaglia P, Turri-Zanoni M, Castelnuovo P, Karligkiotis A. A "Forward Triage" Model in Telemedicine for Head and Neck Oncological Patients During the COVID-19 Era. Ear Nose Throat J. 2021;145561320948995.100(1):16-18. https://doi.org/10.1177/0145561320948995
Nilsen ML, Clump DA, Kubik M, et al. Prevision of multidisciplinary head and neck cancer survivorship care during the 2019 novel coronavirus pandemic. Head Neck. 2020;42(7):1668-1673.
Merkx MA, van Gulick JJ, Marres HA, et al. Effectiveness of routine follow-up of patients treated for T1-2N0 oral squamous cell carcinomas of the floor of mouth and tongue. Head Neck. 2006;28(1):1-7.
Itamura K, Rimell FL, Illing EA, et al. Assessment of Patient Experiences in Otolaryngology Virtual Visits During the COVID-19 Pandemic. OTO Open. 2020;4(2):2473974X20933573.
Layfield E, V. T, A. P,, et al. Telemedicine for head and neck ambulatory visits during COVID-19: Evaluating usability and patient satisfaction. Head Neck. 2020;42(7):1681-1689.
Kanatas A, Rogers SN. The role of the Head and Neck cancer-specific Patient Concerns Inventory (PCI-HN) in telephone consultations during the COVID-19 pandemic. Br J Oral Maxillofac Surg. 2020;58(5):497-499.
Burns CL, Ward EC, Hill AJ, et al. A pilot trial of a speech pathology telehealth service for head and neck cancer patients. J Telemed Telecare. 2012;18(8):443-446.
Green B, Tsiroyannis C, Brennan PA. Human factors - recognising and minimising errors in our day to day practice. Oral dis. 2016;22(1):19-22.
Giuliani M, McQuestion M, Jones J, et al. Prevalence and nature of survivorship needs in patients with head and neck cancer. Head Neck. 2016;38(7):1097-1103.
Henry M, Habib LA, Morrison M, et al. Head and neck cancer patients want us to support them psychologically in the posttreatment period: Survey results. Palliat Support Care. 2014;12(6):481-493.
de Leeuw J, Prins JB, Teerenstra S, Merkx MA, Marres HA, van Achterberg T. Nurse-led follow-up care for head and neck cancer patients: a quasi-experimental prospective trial. Support Care Cancer. 2013;21(2):537-547.
van der Meulen IC, May AM, Ros WJ, et al. One-year effect of a nurse-led psychosocial intervention on depressive symptoms in patients with head and neck cancer: a randomized controlled trial. Oncologist. 2013;18(3):336-344.
van der Meulen IC, May AM, de Leeuw JR, et al. Long-term effect of a nurse-led psychosocial intervention on health-related quality of life in patients with head and neck cancer: a randomised controlled trial. Br J Cancer. 2014;110(3):593-601.